nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0145	0.0146	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0138	0.0139	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0138	0.0139	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0114	0.0114	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0112	0.0113	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0109	0.0109	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0106	0.0107	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.0105	0.0105	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0104	0.0104	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.0104	0.0104	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00959	0.00963	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00932	0.00935	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00915	0.00918	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00899	0.00902	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00893	0.00897	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00877	0.0088	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00857	0.0086	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00844	0.00847	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—KCNJ5—adrenal gland cancer	0.00835	0.00838	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00798	0.00801	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—KCNJ5—adrenal gland cancer	0.00797	0.008	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—KCNJ5—adrenal gland cancer	0.00797	0.008	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00788	0.00791	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00767	0.0077	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00721	0.00724	CbGpPWpGaD
Triazolam—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00713	0.00716	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.007	0.00703	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00688	0.0069	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00676	0.00678	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00671	0.00674	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00659	0.00662	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—KCNJ5—adrenal gland cancer	0.00656	0.00659	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—KCNJ5—adrenal gland cancer	0.00646	0.00649	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—KCNJ5—adrenal gland cancer	0.00612	0.00614	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—KCNJ5—adrenal gland cancer	0.00604	0.00606	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00576	0.00578	CbGpPWpGaD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00556	0.00558	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—KCNJ5—adrenal gland cancer	0.00552	0.00554	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—KCNJ5—adrenal gland cancer	0.00537	0.00539	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0053	0.00532	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0053	0.00532	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—KCNJ5—adrenal gland cancer	0.00527	0.00529	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—KCNJ5—adrenal gland cancer	0.00518	0.0052	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—KCNJ5—adrenal gland cancer	0.00514	0.00516	CbGpPWpGaD
Triazolam—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00506	0.00508	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—KCNJ5—adrenal gland cancer	0.00505	0.00507	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—KCNJ5—adrenal gland cancer	0.00442	0.00443	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00437	0.00438	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0043	0.00432	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00418	0.00419	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00407	0.00408	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00402	0.00403	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00399	0.004	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00399	0.004	CbGpPWpGaD
Triazolam—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.0039	0.00391	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00368	0.00369	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00357	0.00358	CbGpPWpGaD
Triazolam—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00357	0.00358	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00351	0.00352	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00345	0.00346	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00342	0.00344	CbGpPWpGaD
Triazolam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.0034	0.00341	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00336	0.00337	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00328	0.00329	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00323	0.00325	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—PRKACA—adrenal gland cancer	0.0032	0.00321	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00306	0.00307	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—PRKACA—adrenal gland cancer	0.00305	0.00307	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—PRKACA—adrenal gland cancer	0.00305	0.00307	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00302	0.00303	CbGpPWpGaD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.003	0.00301	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00294	0.00295	CbGpPWpGaD
Triazolam—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0029	0.00291	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00286	0.00287	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00286	0.00287	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CDC42—adrenal gland cancer	0.00284	0.00285	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00276	0.00277	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00269	0.0027	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00268	0.00269	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00264	0.00265	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00259	0.0026	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00257	0.00258	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00253	0.00254	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—PRKACA—adrenal gland cancer	0.00251	0.00252	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—PRKACA—adrenal gland cancer	0.00248	0.00249	CbGpPWpGaD
Triazolam—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00235	0.00236	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00235	0.00236	CbGpPWpGaD
Triazolam—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00235	0.00236	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—PRKACA—adrenal gland cancer	0.00234	0.00235	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00232	0.00233	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—PRKACA—adrenal gland cancer	0.00231	0.00232	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00225	0.00226	CbGpPWpGaD
Triazolam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00224	0.00225	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00221	0.00222	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00219	0.0022	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00217	0.00217	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00215	0.00216	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00215	0.00216	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—PRKACA—adrenal gland cancer	0.00212	0.00212	CbGpPWpGaD
Triazolam—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.0021	0.00211	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—PRKACA—adrenal gland cancer	0.00206	0.00206	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—PRKACA—adrenal gland cancer	0.00202	0.00203	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—PRKACA—adrenal gland cancer	0.00198	0.00199	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—BAD—adrenal gland cancer	0.00198	0.00199	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00198	0.00199	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—PRKACA—adrenal gland cancer	0.00197	0.00198	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—PRKACA—adrenal gland cancer	0.00194	0.00194	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00192	0.00193	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00189	0.0019	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00186	0.00186	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00184	0.00185	CbGpPWpGaD
Triazolam—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00182	0.00182	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00181	0.00182	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00177	0.00178	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00174	0.00175	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—BRAF—adrenal gland cancer	0.00173	0.00173	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00172	0.00173	CbGpPWpGaD
Triazolam—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0017	0.00171	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—PRKACA—adrenal gland cancer	0.00169	0.0017	CbGpPWpGaD
Triazolam—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00168	0.00168	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—BRAF—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—BRAF—adrenal gland cancer	0.00165	0.00165	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00164	0.00165	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00164	0.00165	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00163	0.00163	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00158	0.00159	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00149	0.00149	CbGpPWpGaD
Triazolam—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00148	0.00149	CbGpPWpGaD
Triazolam—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00147	0.00148	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00145	0.00145	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00142	0.00143	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.0014	0.0014	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00139	0.00139	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Triazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00137	0.00137	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00136	0.00137	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—BRAF—adrenal gland cancer	0.00136	0.00136	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00135	0.00136	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—BRAF—adrenal gland cancer	0.00133	0.00134	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00133	0.00134	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00133	0.00134	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00133	0.00134	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00131	0.00131	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.0013	0.00131	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—BRAF—adrenal gland cancer	0.00126	0.00127	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00126	0.00126	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.00125	0.00126	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—BRAF—adrenal gland cancer	0.00125	0.00125	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00124	0.00125	CbGpPWpGaD
Triazolam—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0012	0.0012	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.00119	0.00119	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—BRAF—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00114	0.00114	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.00112	0.00112	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—BRAF—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00111	0.00111	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.0011	0.0011	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—BRAF—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00109	0.00109	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00108	0.00108	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—BRAF—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00107	0.00107	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—BRAF—adrenal gland cancer	0.00106	0.00107	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00106	0.00106	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00105	0.00105	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—BRAF—adrenal gland cancer	0.00104	0.00105	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00104	0.00104	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00102	0.00103	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00101	0.00101	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.001	0.00101	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00099	0.000993	CbGpPWpGaD
Triazolam—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000976	0.000979	CbGpPWpGaD
Triazolam—Clobazam—ABCB1—adrenal gland cancer	0.000975	0.264	CrCbGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000922	0.000926	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—BRAF—adrenal gland cancer	0.000912	0.000915	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00091	0.000913	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000905	0.000909	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.000904	0.000907	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000896	0.000899	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00088	0.000883	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000879	0.000883	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000865	0.000868	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000864	0.000867	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000859	0.000862	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000849	0.000852	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000844	0.000847	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000843	0.000846	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000828	0.000831	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000808	0.000811	CbGpPWpGaD
Triazolam—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000791	0.000794	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000783	0.000786	CbGpPWpGaD
Triazolam—Chlorprothixene—ABCB1—adrenal gland cancer	0.000767	0.208	CrCbGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000755	0.000758	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000737	0.00074	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000724	0.000726	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SDHD—adrenal gland cancer	0.00072	0.000723	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—RRM1—adrenal gland cancer	0.00072	0.000723	CbGpPWpGaD
Triazolam—Flurazepam—ABCB1—adrenal gland cancer	0.000716	0.194	CrCbGaD
Triazolam—CYP2C8—Metabolism—SDHB—adrenal gland cancer	0.0007	0.000703	CbGpPWpGaD
Triazolam—Midazolam—ABCB1—adrenal gland cancer	0.000664	0.18	CrCbGaD
Triazolam—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000637	0.00064	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000615	0.000617	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.00057	0.000572	CbGpPWpGaD
Triazolam—Diazepam—ABCB1—adrenal gland cancer	0.000569	0.154	CrCbGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000551	0.000553	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MED12—adrenal gland cancer	0.000537	0.000539	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SDHD—adrenal gland cancer	0.000521	0.000523	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—RRM1—adrenal gland cancer	0.000521	0.000523	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SDHD—adrenal gland cancer	0.000451	0.000453	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—RRM1—adrenal gland cancer	0.000451	0.000453	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000448	0.00045	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.00042	0.000422	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	0.000392	0.000393	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MED12—adrenal gland cancer	0.000388	0.00039	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000376	0.000377	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000367	0.000368	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000367	0.000368	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MED12—adrenal gland cancer	0.000336	0.000338	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GNAS—adrenal gland cancer	0.000318	0.000319	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	0.000312	0.000313	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000301	0.000302	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	0.000283	0.000284	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000274	0.000275	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	0.000245	0.000246	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000245	0.000246	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000242	0.000243	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000242	0.000243	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00024	0.000241	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GNAS—adrenal gland cancer	0.00023	0.00023	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	0.000225	0.000226	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—POMC—adrenal gland cancer	0.000214	0.000215	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.0002	0.0002	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GNAS—adrenal gland cancer	0.000199	0.0002	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000195	0.000196	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	0.000195	0.000196	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000181	0.000181	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	0.000171	0.000171	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000162	0.000162	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000159	0.000159	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—POMC—adrenal gland cancer	0.000155	0.000155	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—POMC—adrenal gland cancer	0.000134	0.000134	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.000132	0.000132	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	0.000123	0.000124	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000109	0.000109	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	0.000107	0.000107	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000107	0.000107	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000105	0.000105	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	8.69e-05	8.72e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.19e-05	7.21e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	5.73e-05	5.75e-05	CbGpPWpGaD
